These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 38204511)

  • 21. Validating a hospital medicines formulary survey in the Western Pacific Region--a global hospital pharmacy initiative based on the Basel Statements.
    Penm J; Chaar B; Moles R
    Res Social Adm Pharm; 2012; 8(4):298-308. PubMed ID: 22169173
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluating a restrictive formulary system by assessing nonformulary-drug requests.
    Green JA; Chawla AK; Fong PA
    Am J Hosp Pharm; 1985 Jul; 42(7):1537-41. PubMed ID: 4025350
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Survey of formulary system policies and procedures.
    Rascati KL
    Am J Hosp Pharm; 1992 Jan; 49(1):100-3. PubMed ID: 1570847
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Disparity in the "time to patient access" to new anti-cancer drugs in Italian regions. Results of a survey conducted by the Italian Society of Medical Oncology (AIOM).
    Gori S; Di Maio M; Pinto C; Alabiso O; Baldini E; Barbato E; Beretta GD; Bravi S; Caffo O; Canobbio L; Carrozza F; Cinieri S; Cruciani G; Dinota A; Gebbia V; Giustini L; Graiff C; Molino A; Muggiano A; Pandoli G; Puglisi F; Tagliaferri P; Tomao S; Venturini M;
    Tumori; 2011; 97(4):442-8. PubMed ID: 21989431
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of Hospital Formularies on Outpatient Prescribing Practices: Analysis of the Introduction of a Local Formulary: A Single-Center, 2-Year Follow-Up, Retrospective Cohort Study of a Local Formulary in Japan.
    Kanai N; Ando M; Shimodate M; Miyazaki Y; Saito T
    Inquiry; 2022; 59():469580221087876. PubMed ID: 35373631
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of the British Columbia reference drug program on hospital formularies: a survey of hospital pharmacy managers.
    Gill NJ; Frighetto L; Marra C; Jewesson P
    Can J Clin Pharmacol; 2000; 7(2):109-14. PubMed ID: 10958707
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Total formulary review--the easy way.
    Chase K; Meyer JD; Kelly WN
    Hosp Pharm; 1984 Mar; 19(3):159-62. PubMed ID: 10265845
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Institutional formularies: the relevance of pharmacoeconomic analysis to formulary decisions.
    Lipsy RJ
    Pharmacoeconomics; 1992 Apr; 1(4):265-81. PubMed ID: 10147017
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of Hospital Formularies in Ontario: Challenges within a Local Health Integration Network.
    Burke N; Bowen JM; Troyan S; Jegathisawaran J; Gosse C; Tonkin M; Kagoma S; Goeree R; Holbrook A
    Can J Hosp Pharm; 2016; 69(3):187-93. PubMed ID: 27402997
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structure and Function of a Provincial Renal Pharmacy Program: Applying the Chronic Care Model to Address Equitable Access to Medication and Pharmacy Services.
    Roohi E; Lo C; Martinusen D; Levin A
    Can J Kidney Health Dis; 2023; 10():20543581231177840. PubMed ID: 37313363
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of one paediatric and one neonatal formulary list in hospital settings.
    Haslund-Krog SS; Rolighed Christensen H; Bjerager M; Holst H
    Br J Clin Pharmacol; 2018 Feb; 84(2):349-357. PubMed ID: 28963995
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Developing a quick reference formulary.
    Huntzinger PE
    Mil Med; 2001 Oct; 166(10):881-3. PubMed ID: 11603239
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neonatal Drug Formularies-A Global Scope.
    Shaniv D; Bolisetty S; Young TE; Mangum B; Ainsworth S; Elbers L; Schultz P; Cucchi M; de Wildt SN; van der Zanden TM; Caldwell N; Smits A; Allegaert K
    Children (Basel); 2023 May; 10(5):. PubMed ID: 37238396
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Managing conflicts of interest in pharmacy and therapeutics committees: A proposal for multicentre formulary development.
    Friesen P; Caplan AL; Miller JE
    J Clin Pharm Ther; 2020 Apr; 45(2):249-255. PubMed ID: 31657022
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association between FDA black box warnings and Medicare formulary coverage changes.
    Dhruva SS; Karaca-Mandic P; Shah ND; Shaw DL; Ross JS
    Am J Manag Care; 2017 Sep; 23(9):e310-e315. PubMed ID: 29087169
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insights on developing a field hospital formulary and medication distribution process in preparation for a second surge of COVID-19 cases.
    Bazzell B; Wagner D; Durant KM; Callahan B
    Am J Health Syst Pharm; 2020 Oct; 77(21):1763-1770. PubMed ID: 32705115
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Formulary systems and pharmacy and therapeutics committees in the Western Pacific Region: exploring two Basel Statements.
    Penm J; Chaar B; Dechun J; Moles R
    Am J Health Syst Pharm; 2013 Jun; 70(11):967-79. PubMed ID: 23686603
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quality control of hospital formularies.
    Rucker TD
    Pharm Weekbl Sci; 1988 Aug; 10(4):145-50. PubMed ID: 3174366
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adherence to the Grampian joint drug formulary in general practice.
    Stewart D; Milne K; Krska J; Downie G
    J Clin Pharm Ther; 1996 Apr; 21(2):79-82. PubMed ID: 8809643
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adherence to the guidelines of a regional formulary.
    Kamps G; Stewart R; van Der Werf G; Schuling J; Jong BM
    Fam Pract; 2000 Jun; 17(3):254-60. PubMed ID: 10846146
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.